The study's findings accentuate the necessity for in‐depth research into IL‐33's specific roles and mechanisms within liver cancer, potentially uncovering new avenues for therapeutic intervention or enhancing the efficacy of existing treatments. The gene discussed is IL33; the disease is liver cancer.